Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Anti-angiogenic therapy can help treat cancer but may cause resistance and side effects, so alternative methods are being explored.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

WNT10A helps esophageal cancer cells spread and keep renewing themselves.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Propranolol can cause reversible hair loss.

Lipedematous scalp is mainly caused by an increase in fat tissue under the skin and is different from lipedematous alopecia.

Minoxidil helps stabilize hair loss, increase density, and reduce shedding after hair transplant surgery.

Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

A woman's eyelashes grew thicker and longer after taking topiramate, but returned to normal when she stopped the medication.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Thymectomy and high-dose prednisolone improved hair loss in a woman with alopecia areata.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Dutasteride reduces DHT more than finasteride, but both drugs improve BPH symptoms similarly.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.